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Abstract 
Background: Obesity nowadays becomes a major medical and social problem in the world. Obesity is a pandemic 
health problem recognized as a disease of time and is also an important cause of morbidity and mortality. The aim of 
this study was to investigate the persistent histopathologic changes after Helicobacter pylori (H. pylori) 
treatment in laparoscopic sleeve gastrectomy (LSG) specimens and correlation between high body mass index 
(BMI) and histopathological findings. 
Materials and Methods: Asymptomatic 520 patients were candidate for laparoscopic sleeve gastrectomy 
(2017-2019) who had not symptom of Helicobacter pylori infection, visually normal endoscopy and had 
positive H. pylori urease recently. They treated with triple regimen (clarithromycin, amoxicillin for 2 weeks 
and proton-pump inhibitor (PPI) for 2 month). Eradication was confirmed by urea breath test (UBT). After 
operation specimens were evaluated histopathologically. 
Results: Females were 58.3% of the patients. Mean BMI were 44.2 (females) and 46.3 (males). Normal LSG 
specimens were 58.3%. Most common abnormal histopathology findings were; chronic mild active and 
inactive gastritis (21.3%), chronic moderate active and inactive gastritis (16.0%), chronic severe active and 
inactive gastritis (3.3%), had not follicular gastritis, lymphoid aggregates (0.6 %), intestinal metaplasia 
(0.2%) and PPI effect (0.2%). Significant correlation was observed between the higher patients BMI 
(BMI>45) with abnormal histopathology findings specially moderate and severe degree of chronic active and 
inactive gastritis. 
Conclusion: Patients with higher BMI was at more risk for post H. pylori treatment abnormal pathology like 
chronic active gastritis which is the risk factor for atrophic gastritis may lead to preventable gastric cancer. 
Patients with higher BMI (≥45) and H. pylori positive urease test with visually normal endoscopy, mainly 
candidate for the laparoscopic Roux-en-Y gastric bypass (LRYGB). Permanent endoscopic follow up in these 
patients are impossible, therefore, endoscopic random tissue mapping even after H. pylori treatment is 
appropriate. 
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Introduction 
Obesity nowadays becomes a major medical and 
social problem in the world. Obesity is a pandemic 
health problem recognized as a disease of time and is 
also an important cause of morbidity and mortality. It 
is estimated that in 2030, medical costs attributed to 
overweight or obesity will be approximately 860 to 
956 billion dollars in the USA1-2. Bariatric surgery is 
increasingly progresses as an important solution. 
Laparoscopic sleeve gastrectomy (LSG) is a 
commonly performed weight loss procedure.  
Laparoscopic Roux-en-Y gastric bypass (LRYGB) is 
the standard bariatric surgery in this serious health 
problem3. After LRYGB surgery, great portion of 
stomach would be out of endoscope access that can 
concern of troublesome pathologies. Some studies 
recommended that endoscopic random biopsies4-6, 
however biopsy taking complications, economic 
burden, accurate case selection according to 
abnormal histopathologic risk factors and 
associations, it would be valuable7-9. The great 
portion of the stomach resects in LSG is from 
fondus, most part of the corpus and antrum, rather 
same parts is out of access in RYGB. Therefore, 
maybe it is appropriate for investigational purposes 
of risk factors behavior. Some studies state that there 
is no histopathologic anomaly in most LSG cases, 
other claim that there is gastric pathology in the least 
half of them. Some pathologists reported that in 
obese patients who were undergoing LSG had 
chronic active and inactive superficial gastritis, 
atrophy, intestinal metaplasia (IM), Helicobacter 
pylori, lymphoid aggregates and follicles10-12. Onzi et 
al, reported in their study the inflammatory 
alterations in the pre-operative period were mainly 
foveolar hyperplasia and chronic gastritis associated 
with H. pylori, and they had reduced in the 
postoperative period. Thus, a significant reduction of 
weight and BMI occurred and a resolution of 
comorbidities was observed13. Ohanessian et al 
reported, despite negative preoperative H. pylori 
testing, 3.2% were still histologically positive that 
raising question about the accuracy of preoperative 
methods used for H. pylori testing and treatment. 
Preoperative endoscopy may not be needed in sleeve 
patients14. Saafan et al, showed there was a weak 
correlation between BMI and other covariates15. 
Taskin et al. showed a correlation of histopathologic 
changes in morbid obese patients with weight loss 
after bariatric surgery. Operating on younger patients 
with lower BMI and inactive gastritis with the LSG 
method could contribute to achieving more successful 
results16.  
Obesity increases inflammation in intestines and 
stomach17. In obese individuals, the intestinal flora is 
different from the individuals with normal weight. 
High-tissue permeability in the gastrointestinal lumen 
for toxic and irritant materials and some bacteria may 
cause gastrointestinal pathologies, primarily ulcers5. 
High prevalence of Helicobacter pylori infection and 
its role as a known risk factor of gastric cancer and 
LSG rapid developing as a main bariatric operation, 
such considerations highlight the importance of this 
studies18. The aim of this study was to investigate the 
spectrum of post Helicobacter pylori treatment 
histopathologic findings detected in LSG specimens. 
In addition, assess routine preoperative 
esophagogastroduodenoscopy for Helicobacter pylori 
screening. Also histopathologic surveyed of LSG 
specimen to find that it enough in patients with no 
significant clinical history and normal endoscopy. 
Methods 
The prospective nonrandomized clinical trial study 
was done at Loghman Hakim general hospital in 2017-
19. Patients who were candidate for LSG underwent 
screen esophagogastrodedonoscopy and we used rapid 
urease test to detect H. pylori. A total of 714 patients 
who reported no history of prior peptic disease 
symptoms or who had minimal symptoms and no 
history of H. pylori infection with no visual findings in 
their upper gastrointestinal (GI) endoscopy that only 
they had positive H. pylori urease test included in this 
study. For reducing of confounding risk factors, 
patients should not smoker, alcohol drinking, frequent 
NSAID and caffeine use for 6 months. Afterward, 194 
patients who were not successful were excluded. 
Ethics committee approval for the research was 
obtained from the ethics committee. Finally, 520 
patients included. Patients were informed about the 
study and their written consents were obtained. All 
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included patients treated with standard H. pylori 
regimen included triple therapy (proton pump 
inhibitor (PPI), clarithromycin and amoxicillin) for 2 
weeks and PPI for 2 month17 which considered to be 
the best-tolerated and safest. For close supervision of 
patient bounding to treatment, good justification of 
patient and his or her family and close friends about 
regimen and soluble complications and intermittent 
calls were done. confirming the eradication realized 
by urease breath test (UBT) because it is available‚ 
noninvasive, inexpensive and highly sensitive and 
specific. For reduction of false negative results, the 
test performed 2 weeks after PPI withheld18 after 
negative UBT test result, patients underwent the LSG 
during 2-4 weeks later. All gastric specimens 
examined by our histopathology department macro- 
and microscopically and results were reported in 
automation system. Statistical analyses were 
performed using SPSS version 24. Chi-square test 
and Fishers exact test were applied for evaluate 
statistical correlations. The ethical committee of the 
Shahid Beheshti University of Medical Sciences 
approved this study 
(IR.SBMU.RETECH.REC.1399.408). 
Results 
General characteristics of participants are shown in 
the table 1 shows the demographic, anthropometric 
and clinical characteristics of LSG patients (N=520). 
A total of 56.2% of participants were females. Mean 
age for females and males were 38.3 and 39 years 
and mean BMI for females and males 44.2 and 46.3. 
Comorbidities as HTN and DM2 and hypothyroidism 
were present in 39.9%, 40.2%, 16.7%, 14.4% and 
14.4 for females, 18.2% of males respectively. 
Distribution of histopathologic findings a total of 
58.3% of the histopathology sample were normal and 
no pathologic alteration was reported. Almost 5% of 
specimens reported positive for H. pylori 
colonization. The most common abnormal 
histopathology were mild chronic active and inactive 
gastritis (21.3%), chronic moderate active and 
inactive gastritis (16.0%), chronic sever active and 
inactive gastritis (3.3%), lymphoid aggregates 
(0.6%), intestinal metaplasia (0.2%) and no ulcer or 
malignant lesions and proton pump effect (0.2%) 
were reported. We categorized the abnormal 
histopathology included mild changes like mild 
inflammation, mild chronic inactive gastritis, mild 
chronic active gastritis, moderate changes like 
moderate inflammation, moderate chronic inactive 
gastritis, moderate chronic active gastritis and severe 
changes like severe inflammation, severe chronic 
inactive gastritis, severe chronic active gastritis. 
lymphocyte aggregation and intestinal metaplasia was 
recorded. 
Normal pathology was seen mainly in BMI<45, but 
moderate and severe pathologies ware BMI≥45. There 
were statistically significant correlation between 
BMI≥45 and moderate and severe pathology (P=0.000 
and Pearson correlation coefficient 38.76). H. pylori 
positive colonization cases had normal pathology less 
than abnormal pathology but there was no significant 
statistical correlation between H. pylori and pathology 
with Fisher exact test. There were no statistically 
significant correlation between age and gender with 
abnormal pathologies. 
Discussion 
Helicobacter pylori induce progressive inflammatory 
changes in the gastric mucosa that may lead to gastric 
cancer. Understanding the long-term effects resulting 
from the cure of this infection needed to design cancer 
prevention strategies18. The persistence of chronic 
inflammation in gastric mucosa, after successful 
eradication therapy are common findings in clinical 
practice5. Some studies based on H. pylori 
histopathology findings was according to endoscopic 
biopsies with its limitations5,7. Dogan et al observed 
that the prevalence of active follicular gastritis, 
chronic active gastritis and H. pylori positivity, were 
high in morbidly obese in Turkish patient population. 
No significant difference was found between the 
pathological diagnosis in obese patients with LSG 
operation in terms of age and sex. Studies have shown 
that obesity has seen in gastric pathologies. The 
treatment of gastric pathologies is important in the 
follow-up of patients and in the success of bariatric 
surgery19. We found a significant in our patients that 
had no pathologic alteration. Results had differences 
from other studies that reported a high prevalence of 
positive histopathology (almost 100%) in patients 
undergoing LSG. Histopathologic findings in LSG in 
an American database showed that the most 
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prevalence diagnosis in LSG had “no significant 
pathologic change”, but this was seen in our study 
just in 35.2% of cases. The most common pathology 
found in their series of 250 LSG were lymphoid 
aggregates (31.2 %), chronic inflammation (12 %), 
and gastritis (12 %)11,20. We also found that the most 
common pathology finding in our study was chronic 
gastritis (including both inactive and active gastritis) 
however; this was seen in a relatively less percentage 
of cases21. Some pathologists interpret chronic 
gastritis when see presence of occasional plasma 
cells in samples, while others require a significant 
expansion of laminapropria to diagnose chronic 
gastritis21-22. The other reason may be based on 
different databases. We found small percentage of 
patients in our study that had H. pylori positive (5%). 
The most important difference between our study and 
prior ones was, all of prior studies paid to report their 
histopathologic findinges23-24, but in our study we 
select one of the most challenging groups specially, 
asymptomatic H. pylori positive patients with normal 
endoscopy that after appropriate treatment and 
confirming test studied the pathologies. Thus 
differences were inevitable. There exists a noticeable 
deficiency in the published literature that examined the 
relationships between different histopathology of LSG 
specimens and BMI. 
A study in USA found no significant difference 
between LSG specimens with abnormal pathology (i.e. 
not containing H. pylori or gastric metaplasia) vs. 
specimens with significant pathology (i.e. containing 
H. pylori or gastric metaplasia)25. Likewise, others 
reported no significant relationship between BMI and 
presence or absence of gastric atrophy, H. pylori, 
Table 1: General demographic characteristics of patients  
  
                                                       Female                                 Male  
Age (years) 
 M±SD                                        38.3±11.4                                39±11.3  
Range                                        15–65                                          15–60 
 BMI 
 M±SD                                      44.2±5.1                                    46.3±2.1  
Range                                      35-50                                             38–56 
 H. pylori colonization 
 Yes (%)                                     2
 3 
 Hypertension                       
 Yes (%)                                    39.9                                                 40.2         
 Diabetes mellitus  
Yes(%)                                      16.7                                                   14.4 
 Hypothyroidism 
Yes (%)                                      14.4                                                18.2                                     
 
 Table 2: Distribution of histopathologic findings 
 
Histopathology of LSG Specimen n (%) 
 
Normal histopathology                                                                                        303 
(58.3)  
Abnormal histopathology                                                                                  217(41.7) 
 Chronic active and inactive gastritis (mild)                                                     111 (21.3) 
Chronic active and inactive gastritis( moderate)                                           83(16) 
Chronic active and inactive gastritis(sever)                                                    17(3.3) 
Lymphoid aggregate                                                                                            3 (0.6)  
 Intestinal metaplasia                                                                                          1(0.2) 
PPI effect                                                                                                                2(0 .4) 
Ulcer                                                                                                                         0 
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lymphoid follicle and lymphoid aggregates11,20,26. An 
exception was in the intestinal metaplasia, which was 
associated with lower BMI (40.8) when compared to 
other abnormal specimens (atrophy, H. pylori, 
lymphoid follicle and lymphoid aggregate) that did 
not have intestinal metaplasia (BMI 44.9, 
p<0.0001)18. However, another study observed that 
patients with gastrointestinal stromal tumor (GIST), 
intestinal metaplasia or lymphoid aggregates had 
generally higher BMI compared to patients without 
these particular conditions or compared to patients 
with normal histopathology, but the differences were 
not statistically significant14,27. Likewise, in that 
study, patients with follicular gastritis generally 
exhibited higher BMI than patients without such 
pathology or compared to patients with normal LSG 
specimens (BMI of follicular gastritis patients 48.3 
vs. other histopathology (46.6) vs. normal (46.5), but 
again, and differences were not statistically 
significant5. 
In Safaan study, among 1555 patients who had LSG, 
after controlling for confounding variables (age, 
gender, H. pylori, diabetes mellitus type 2, 
hypertension), there was no significant association 
between BMI and either the different benign or pre-
malignant histopathology identified in their gastric 
specimens. Moreover, there was a weak correlation 
between BMI and the other covariates (age, gender, 
H. pylori, HTN, DM2)15. Onzie et al deliberated the 
histologic inflammatory pattern found in the 
preoperatively morbidly obese patients who 
underwent LSG was not reproduced in the evaluation 
of the same patients after 6 months post-operative13. 
A statistically significant reduction of weight and 
BMI after 6 months post-operative of patients who 
underwent LSG occurred. A reduction in incidence 
of comorbidities was verified after the LSG was 
performed, indicating an improvement in the quality 
of life of these patients14. Most of the previous 
studies that histopathology investigated, were 
retrospective and there was not noticeable study 
targeted H. pylori effect on gastric histopathology. 
According to some studies histopathology gastric can 
lead to LSG outcome failure16 therefore evaluate the 
risk factors effect one by one with reduction of 
confounding elements will be helpful for guidelines 
in this course. The correlation between post H. pylori 
treatment persistent histopathologic changes (gastritis) 
and BMI is asserted in this study. There was no 
statistical significant correlation between post 
treatment H. pylori colonization and persistent 
histopathologic changes. The lymphoid aggregations 
was rare in our study but were more in the BMI≥45. 
We had only one IM which discovered in 45 years old 
man with BMI=48.3 without H. pylori colonization 
although it was not valuable statistically but this 
pathology after appropriate H. pylori treatment was 
noticeable clinically.  
Our study was mono-centric, we recommend the 
multi-centric and large samples and investigate several 
risk factors. 
Conclusion 
In patients with higher BMI (≥45) and H. pylori 
positive with visually normal endoscopy who were 
scheduled for LRYGB‚ the conditions that permanent 
endoscopic follow up will be impossible, gain benefit 
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